177 related articles for article (PubMed ID: 18425827)
1. Positive contrast MR-lymphography using inversion recovery with ON-resonant water suppression (IRON).
Korosoglou G; Tang L; Kedziorek D; Cosby K; Gilson WD; Vonken EJ; Schär M; Sosnovik D; Kraitchman DL; Weiss RG; Weissleder R; Stuber M
J Magn Reson Imaging; 2008 May; 27(5):1175-80. PubMed ID: 18425827
[TBL] [Abstract][Full Text] [Related]
2. MR lymphography using iron oxide nanoparticles in rats: pharmacokinetics in the lymphatic system after intravenous injection.
Réty F; Clément O; Siauve N; Cuénod CA; Carnot F; Sich M; Buisine A; Frija G
J Magn Reson Imaging; 2000 Nov; 12(5):734-9. PubMed ID: 11050643
[TBL] [Abstract][Full Text] [Related]
3. Off-resonance angiography: a new method to depict vessels--phantom and rabbit studies.
Korosoglou G; Shah S; Vonken EJ; Gilson WD; Schär M; Tang L; Kraitchman DL; Boston RC; Sosnovik DE; Weiss RG; Weissleder R; Stuber M
Radiology; 2008 Nov; 249(2):501-9. PubMed ID: 18780823
[TBL] [Abstract][Full Text] [Related]
4. Interstitial MR lymphography with iron oxide particles: results in tumor-free and VX2 tumor-bearing rabbits.
Taupitz M; Wagner S; Hamm B; Binder A; Pfefferer D
AJR Am J Roentgenol; 1993 Jul; 161(1):193-200. PubMed ID: 8517301
[TBL] [Abstract][Full Text] [Related]
5. MR lymphography: evidence of extravasation of superparamagnetic nanoparticles into the lymph.
Clement O; Rety F; Cuenod CA; Siauve N; Carnot F; Bordat C; Siche M; Frija G
Acad Radiol; 1998 Apr; 5 Suppl 1():S170-2; discussion S183-4. PubMed ID: 9561073
[No Abstract] [Full Text] [Related]
6. Distribution of iron oxide nanoparticles in rat lymph nodes studied using electron energy loss spectroscopy (EELS) and electron spectroscopic imaging (ESI).
Bordat C; Sich M; Réty F; Bouet O; Cournot G; Cuénod CA; Clément O
J Magn Reson Imaging; 2000 Sep; 12(3):505-9. PubMed ID: 10992320
[TBL] [Abstract][Full Text] [Related]
7. Biodistribution of an ultrasmall superparamagnetic iron oxide colloid, BMS 180549, by different routes of administration.
Bengele HH; Palmacci S; Rogers J; Jung CW; Crenshaw J; Josephson L
Magn Reson Imaging; 1994; 12(3):433-42. PubMed ID: 8007773
[TBL] [Abstract][Full Text] [Related]
8. [Sentinel lymph node after intramammary injection of superparamagnetic iron oxide].
Ishiyama K; Sashi R; Katayose Y; Tomura N; Watarai J; Narita K
Nihon Igaku Hoshasen Gakkai Zasshi; 2002 Nov; 62(13):744-6. PubMed ID: 12508494
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance lymphography in rats: effects of muscular activity and hyperthermia on the lymph node uptake of intravenously injected superparamagnetic iron oxide particles.
Elste V; Wagner S; Taupitz M; Pfefferer D; Kresse M; Hamm B; Berg R; Wolf KJ; Semmler W
Acad Radiol; 1996 Aug; 3(8):660-6. PubMed ID: 8796730
[TBL] [Abstract][Full Text] [Related]
10. Experimental investigation of the delivery pathway of ultrasmall superparamagnetic iron oxide to lymph nodes.
Frija G; Clément O; Le Guen O; Cuénod CA; Siauve N; Benderbous S
Acad Radiol; 1996 Aug; 3 Suppl 2():S299-300. PubMed ID: 8796586
[No Abstract] [Full Text] [Related]
11. Long-term imaging effects in rat liver after a single injection of an iron oxide nanoparticle based MR contrast agent.
Briley-Saebø K; Hustvedt SO; Haldorsen A; Bjørnerud A
J Magn Reson Imaging; 2004 Oct; 20(4):622-31. PubMed ID: 15390223
[TBL] [Abstract][Full Text] [Related]
12. MR lymphography: study of a high-efficiency lymphotrophic agent.
Weissleder R; Heautot JF; Schaffer BK; Nossiff N; Papisov MI; Bogdanov A; Brady TJ
Radiology; 1994 Apr; 191(1):225-30. PubMed ID: 8134576
[TBL] [Abstract][Full Text] [Related]
13. Dextran-coated superparamagnetic iron oxide, an MR contrast agent for assessing lymph nodes in the head and neck.
Anzai Y; McLachlan S; Morris M; Saxton R; Lufkin RB
AJNR Am J Neuroradiol; 1994 Jan; 15(1):87-94. PubMed ID: 7511324
[TBL] [Abstract][Full Text] [Related]
14. MR lymphography with superparamagnetic iron nanoparticles in rats: pathologic basis for contrast enhancement.
Guimaraes R; Clément O; Bittoun J; Carnot F; Frija G
AJR Am J Roentgenol; 1994 Jan; 162(1):201-7. PubMed ID: 8273666
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced MR imaging of liver and spleen: first experience in humans with a new superparamagnetic iron oxide.
Hamm B; Staks T; Taupitz M; Maibauer R; Speidel A; Huppertz A; Frenzel T; Lawaczeck R; Wolf KJ; Lange L
J Magn Reson Imaging; 1994; 4(5):659-68. PubMed ID: 7981510
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of an ultrasmall superparamagnetic iron oxide in MRI in a bone tumor model in rabbits.
Bush CH; Mladinich CR; Montgomery WJ
J Magn Reson Imaging; 1997; 7(3):579-84. PubMed ID: 9170045
[TBL] [Abstract][Full Text] [Related]
17. MR lymphography using iron oxide particles. Detection of lymph node metastases in the VX2 rabbit tumor model.
Taupitz M; Wagner S; Hamm B; Dienemann D; Lawaczeck R; Wolf KJ
Acta Radiol; 1993 Jan; 34(1):10-5. PubMed ID: 8427741
[TBL] [Abstract][Full Text] [Related]
18. Pelvic lymph node visualization with MR imaging using local administration of ultra-small superparamagnetic iron oxide contrast.
McCauley TR; Rifkin MD; Ledet CA
J Magn Reson Imaging; 2002 Apr; 15(4):492-7. PubMed ID: 11948841
[TBL] [Abstract][Full Text] [Related]
19. Imaging of macrophages in soft-tissue infection in rats: relationship between ultrasmall superparamagnetic iron oxide dose and MR signal characteristics.
Lutz AM; Weishaupt D; Persohn E; Goepfert K; Froehlich J; Sasse B; Gottschalk J; Marincek B; Kaim AH
Radiology; 2005 Mar; 234(3):765-75. PubMed ID: 15665219
[TBL] [Abstract][Full Text] [Related]
20. Differences in predominant enhancement mechanisms of superparamagnetic iron oxide and ultrasmall superparamagnetic iron oxide for contrast-enhanced portal magnetic resonance angiography. Preliminary results of an animal study original investigation.
Knollmann FD; Böck JC; Rautenberg K; Beier J; Ebert W; Felix R
Invest Radiol; 1998 Sep; 33(9):637-43. PubMed ID: 9766048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
